Yasmin Hasan to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Yasmin Hasan has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.169
-
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2023 02 14; 7(3):285-292.
Score: 0.098
-
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet Haematol. 2018 May; 5(5):e190-e200.
Score: 0.070